NVCR

NASDAQStock

NovoCure Limited

$12.00-0.01 (-0.08%)

52-Week Range

$10.03

$19.78

Key Stats

Market Cap

1.4B

P/E Ratio

—

Dividend Yield

—

Beta

0.74

Volume

383.9K

Avg Volume

2.3M

Performance

-4.15%

-7.40%

-5.58%

YTD

-8.46%

-38.38%

-81.68%

-91.49%

Price Chart

ETF Exposure

NVCR is held by 114 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	36	$453	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	27	$342	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	12	$152	$9.3M	0.12%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	1,617	$19K	$1.43B	0.09%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	1,434	$18K	$1.46B	0.24%
V3AM.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	1,434	$13K	$1.09B	0.24%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	5,900	$99K	$12.17B	0.24%
VT	Vanguard Total World Stock ETF	0.00%	73,547	$912K	$80.60B	0.06%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	129,739	$129K	$14.63B	0.20%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	9	$107	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	28	$355	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	48	$605	$80.4M	0.11%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	165	$3K	$820.6M	0.25%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	28	$479	$337.7M	0.32%

PreviousPage 3 of 3

About NVCR ETF Exposure

NovoCure Limited (NVCR) is held by 114 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.4B, NVCR is a widely held institutional stock. The stock currently trades at $12.00. Investors can gain exposure to NVCR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NVCR, sorted by portfolio weight.